NCT00304382View on ClinicalTrials.gov

Humoral Determinants of Immunity to Pneumococcal Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 1, 2003

Primary Completion Date

September 1, 2006

Study Completion Date

June 1, 2012

Conditions
PneumoniaPneumococcal InfectionsInfections, Streptococcus Pneumoniae
Interventions
BIOLOGICAL

Prevnar

0.5 ml IM into each deltoid muscle one time (or two in group PCV-PCV)

BIOLOGICAL

Pneumovax

0.5 ml IM one time

Trial Locations (1)

77030

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

All Listed Sponsors
collaborator

Michael E. DeBakey VA Medical Center

FED

lead

VA Office of Research and Development

FED

NCT00304382 - Humoral Determinants of Immunity to Pneumococcal Infection | Biotech Hunter | Biotech Hunter